Barclays analyst Matt Miksic lowered the firm’s price target on Zimmer Biomet (ZBH) to $118 from $125 and keeps an Underweight rating on the ...

In a report released today, Matt Miksic from Barclays maintained a Sell rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

Shares of Zimmer Biomet Holdings Inc. ZBH dropped 0.98% to $108.40 Tuesday, on what proved to be an all-around grim trading ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

The global orthopedic implants market is projected to grow USD 26.47 billion in 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Technology improvements, rising opportunities ...

WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a global leader in medical technology, announced today the U.S. Food and Drug Administration (FDA) has granted Premarket Approval for its ...

WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a global leader in medical technology, announced today the U.S. Food and Drug Administration (FDA) has granted Premarket Approval for its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...